Search research articles
Contact Us
Filters
Showing results (21-30 of 82) with videos related to
Page
of 9
Sort By:
Pharmacology, Biochemistry, and Behavior
|
July 23, 2011
Adolescent cannabinoid exposure attenuates adult female sexual motivation but does not alter adulthood CB1R expression or estrous cyclicity
Benjamin Chadwick, Alicia J Saylor, Hassan H López
JCO Oncology Practice
|
February 20, 2020
Bone Health and Bone-Targeted Therapies for Prostate Cancer: American Society of Clinical Oncology Endorsement Summary of a Cancer Care Ontario Guideline
Philip J Saylor, R Bryan Rumble, Jeff M Michalski
Journal of General Internal Medicine
|
October 20, 2009
Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy
Philip J Saylor, Nancy L Keating, Matthew R Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2011
Emerging therapies to prevent skeletal morbidity in men with prostate cancer
Philip J Saylor, Richard J Lee, Matthew R Smith
Clinical Genitourinary Cancer
|
January 7, 2011
Contemporary therapeutic approaches targeting bone complications in prostate cancer
Richard J Lee, Philip J Saylor, Matthew R Smith
Bone
|
July 13, 2010
Treatment and prevention of bone complications from prostate cancer
Richard J Lee, Philip J Saylor, Matthew R Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2012
Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancer
Philip J Saylor, Edward D Karoly, Matthew R Smith
AJR. American Journal of Roentgenology
|
May 25, 2011
Prostate cancer imaging: what surgeons, radiation oncologists, and medical oncologists want to know
Shahin Tabatabaei, Philip J Saylor, John Coen, et al.
Plos One
|
February 9, 2018
Validity and reliability of an accelerometer-based player tracking device
Daniel P Nicolella, Lorena Torres-Ronda, Kase J Saylor, et al.
The Oncologist
|
September 19, 2014
Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data
Charles J Ryan, Philip J Saylor, Jason J Everly, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 82) with videos related to
Sort By:
Page
of 9
Pharmacology, Biochemistry, and Behavior
|
July 23, 2011
Adolescent cannabinoid exposure attenuates adult female sexual motivation but does not alter adulthood CB1R expression or estrous cyclicity
Benjamin Chadwick, Alicia J Saylor, Hassan H López
JCO Oncology Practice
|
February 20, 2020
Bone Health and Bone-Targeted Therapies for Prostate Cancer: American Society of Clinical Oncology Endorsement Summary of a Cancer Care Ontario Guideline
Philip J Saylor, R Bryan Rumble, Jeff M Michalski
Journal of General Internal Medicine
|
October 20, 2009
Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy
Philip J Saylor, Nancy L Keating, Matthew R Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2011
Emerging therapies to prevent skeletal morbidity in men with prostate cancer
Philip J Saylor, Richard J Lee, Matthew R Smith
Clinical Genitourinary Cancer
|
January 7, 2011
Contemporary therapeutic approaches targeting bone complications in prostate cancer
Richard J Lee, Philip J Saylor, Matthew R Smith
Bone
|
July 13, 2010
Treatment and prevention of bone complications from prostate cancer
Richard J Lee, Philip J Saylor, Matthew R Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2012
Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancer
Philip J Saylor, Edward D Karoly, Matthew R Smith
AJR. American Journal of Roentgenology
|
May 25, 2011
Prostate cancer imaging: what surgeons, radiation oncologists, and medical oncologists want to know
Shahin Tabatabaei, Philip J Saylor, John Coen, et al.
Plos One
|
February 9, 2018
Validity and reliability of an accelerometer-based player tracking device
Daniel P Nicolella, Lorena Torres-Ronda, Kase J Saylor, et al.
The Oncologist
|
September 19, 2014
Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data
Charles J Ryan, Philip J Saylor, Jason J Everly, et al.
Page
of 9